for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Notre Dame Intermedica Participacoes SA

GNDI3.SA

Latest Trade

60.00BRL

Change

0.55(+0.93%)

Volume

4,752,400

Today's Range

59.30

 - 

60.25

52 Week Range

27.83

 - 

63.12

As of on the Bolsa de Valores do Estado de Sao Paulo ∙ Minimum 15 minute delay

Pricing

Previous Close
59.45
Open
59.76
Volume
4,752,400
3M AVG Volume
63.03
Today's High
60.25
Today's Low
59.30
52 Week High
63.12
52 Week Low
27.83
Shares Out (MIL)
603.39
Market Cap (MIL)
36,221.59
Forward P/E
59.67
Dividend (Yield %)
--

Latest Developments

More

Brazilian Healthcare Provider Intermedica Buys Smaller Rival Clinipam For 2.6 Billion Reais- Filing

Brazilian Healthcare Provider Intermedica Buys Smaller Rival Ghelfond For 240 Million Reais- Filing

Brazil's Notre Dame Intermedica says its share offering has raised 2.67 billion reais - filing

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Notre Dame Intermedica Participacoes SA

Notre Dame Intermedica Participacoes SA (Notre Dame), formerly known as BCBH Participacoes SA, is a Brazil-based company specialized in the healthcare industry. The Company operates as the holding company of the NotreDame Intermedica Group. Notre Dame has offices in Sao Paulo, Rio de Janeiro, Jundai, Campinas, Sorocaba and Baixada Santista and through its subsidiaries offers different medical services in Brazil. The Company owns more than 15 hospitals, more than 20 emergency rooms, more than 10 units of preventive medicine and more than 65 clinical centers. Notre Dame through its subsidiaries offers health services; dental services, which includes dental plans, preventive dentistry and online contact, and other specialized services as child surgery or occupational health.

Industry

Healthcare Facilities

Contact Info

Bela Vista

+55.11.31559276

Key Stats

1.89 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, BRL)

2018

6.1K

2019(E)

8.3K
EPS (BRL)

2018

0.640

2019(E)

1.028
Price To Earnings (TTM)
79.21
Price To Sales (TTM)
4.68
Price To Book (MRQ)
11.90
Price To Cash Flow (TTM)
57.83
Total Debt To Equity (MRQ)
108.41
LT Debt To Equity (MRQ)
83.79
Return on Investment (TTM)
7.92
Return on Equity (TTM)
5.70

Latest News

Latest News

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

Brazilian healthcare co Notre Dame Intermedica buys Clinipam for $653 million

Brazilian healthcare company Notre Dame Intermedica Participações <GNDI3.SA> announced onMonday the acquisition of medical health insurance company Clinipam for 2.6 billion reais ($653 million).

Brazil healthcare provider Notre Dame prices follow-on at 26 reais per share

Brazilian healthcare provider Notre Dame Intermedica Participações SA priced its follow-on offering at 26 reais per share, the company said in a securities filing on Thursday.

Brazilian healthcare provider Intermédica mulls share offering

Brazilian healthcare provider Notre Dame Intermédica Participações SA said on Thursday in a securities filing it is considering a new share offering, without disclosing further details.

UPDATE 1-Brazil's Intermedica to buy rival healthcare provider Green Line -filing

Brazilian healthcare provider Notre Dame Intermedica Participações SA said on Wednesday in a securities filing that it intends to acquire smaller rival Green Line Group.

Brazil's Intermedica buys rival healthcare provider Green Line -filing

Brazilian healthcare provider Notre Dame Intermedica Participações SA said on Wednesday in a securities filing that it acquired smaller rival Green Line Group.

Brazil shoemaker Dass cancels IPO on weak demand: source

Brazilian shoemaker Dass Nordeste Calçados e Artigos Esportivos SA has decided to cancel its initial public offering because of weak demand, according to a source familiar with the matter.

Brazilian shoemaker Dass may cancel IPO on weak demand -source

Brazilian shoemaker Dass Nordeste Calçados e Artigos Esportivos SA may cancel its initial public offering because of weak demand, according to a source familiar with the matter.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up